Purchase Order 75N91021P00756
Award Date 9/2/21
Potential Completion Date 10/2/21
Potential Value $96K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94306, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $389,973 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Ai Biosciences, Inc., a small disadvantaged biotechnology company. The contract is for the development of a "Rapid Isothermal Amplification Chip for HPV Detection and Genotyping in Low-Resource Settings." This aligns with NCI's mission to support cancer research and diagnostic technologies,...
- This firm-fixed-price purchase order, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to CD Biosciences Inc., doing business as Creative Biomart, provides $55,100.00 for HPV genotyping and 16S rRNA sequencing services. The contract supports research on the progression of HPV-related diseases and dysplasia in individuals with primary and acquired immunodeficiencies. CD Biosciences, an incumbent supplier, will conduct HPV genotyping for 210 types and 16S rRNA...
- This is a $382,034 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Phoenix Biosystem, Inc., a self-certified small disadvantaged business. The contract is for the development of HPV point-of-care molecular diagnostics for low- and middle-income countries. The original pre-solicitation announced that NIH and CDC were seeking SBIR proposals to advance their infectious...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $19,303.20 purchase order to Agilent Technologies Inc. Customer Service And Sales Division for the delivery of biological kits. As the prime contractor, Agilent Technologies Inc. will provide the requested biological kits to support the National Cancer Institute's research efforts. The contract has a period of performance from August 1, 2023 through September 1, 2023 and utilizes a...
- This federal contract award is for the procurement of biological kits for the Laboratory of Pathology at the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services. The contract, valued at $18,195.96, was awarded to Invivoscribe, Inc., a for-profit manufacturer of goods specializing in precision diagnostics, molecular testing, and biological research products. The contract is a firm fixed-price purchase order with an ultimate completion date of June...
- This federal contract award to American Type Culture Collection (ATCC), a nonprofit biological resource center, is for biospecimen and assay support services under the National Cancer Institute's (NCI) Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services IDIQ contract. The task order, valued at $5,394,205.00, has a period of performance from January 12, 2024 to September 25, 2029. ATCC will provide a range of specialized biological services, including...
- <p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>
- The Department of Health and Human Services' National Institutes of Health's National Cancer Institute awarded a $32,933.88 delivery order against Agilent Technologies Inc.'s Multiple Award Schedule contract for unspecified services in support of the agency's programs. To be performed in Bethesda, Maryland through January 2025, the firm fixed price contract calls for Agilent Laboratory, doing business as Agilent Labs, to provide products and services to the National Cancer Institute, which...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $16,265 purchase order to Capralogics Inc. for testing services. The firm fixed price contract will be performed in Hardwick, Massachusetts over a three-month period from July 1, 2023 through September 30, 2023. As the intramural research program of the NCI, a component of the NIH focused on cancer research, this contract supports the agency's mission to lead the nation's...
- <p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Genus Biosystems Inc., a for-profit organization, for $23,520.00 to provide lab testing services. The contract has a completion date of November 1, 2024 and was awarded on May 1, 2024. The place of performance is Northbrook, IL 60062, USA. This contract award is not associated with any set-aside designation.</p>